BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:21 PM
 | 
Mar 24, 2008
 |  BC Extra  |  Clinical News

Cytokinetics presents heart failure data

Cytokinetics (NASDAQ:CYTK) said interim Phase IIa data showed that CK-1827452 significantly improved indices of cardiac ventricular function vs. placebo in patients with stable heart...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >